Comerica Rises 21.8% in 3 Months: How to Approach the Stock Now?

Comerica (CMA) shares gained 21.8% over the past three months, outperforming its industry, primarily driven by anticipated Federal Reserve rate cuts expected to boost Net Interest Income (NII) by 5-7% in 2025, alongside steady loan growth, robust liquidity, and strong capital distribution initiatives. However, the bank faces challenges from rising non-interest expenses and a significant 81.2% concentration in commercial and real estate loans as of June 30, 2025. With the stock currently trading at a premium 12.91x forward P/E compared to the industry average of 11.79x, the article suggests new investors exercise caution and await a more favorable entry point.

Analysis

Comerica Incorporated (CMA) has demonstrated significant market outperformance, with its shares gaining 21.8% over the past three months, surpassing the industry's 13.9% growth and that of peers like BankUnited and Northern Trust. This rally is underpinned by several fundamental strengths, notably a positive outlook for Net Interest Income (NII), which management projects will grow 5-7% in 2025, aided by anticipated Federal Reserve rate cuts. The bank maintains a solid liquidity profile, with $40.5 billion in total liquidity capacity against $8.7 billion in debt as of June 30, 2025. Furthermore, Comerica's commitment to capital returns is robust, featuring a 4.03% dividend yield that exceeds the industry average and an active share repurchase program targeting 1.5 million shares in Q3 2025. Operational efficiency is also improving, as evidenced by a decline in the efficiency ratio to 65.8% in Q2 2025 from 67.8% a year prior. However, these positive factors are counterbalanced by significant risks. The bank's loan portfolio exhibits a high concentration risk, with commercial and commercial mortgage loans accounting for 81.2% of total loans, posing a vulnerability to macroeconomic headwinds. Additionally, while non-interest expenses declined in the first half of 2025, they have a five-year CAGR of 5.3% and are expected to rise in the third quarter, potentially pressuring the bottom line. From a valuation perspective, CMA trades at a forward P/E multiple of 12.91x, a premium to the industry average of 11.79x, suggesting the recent positive performance may be fully priced in.

Key Decisions for Investors

• Given the stock's 21.8% recent appreciation and premium forward P/E ratio of 12.91x, investors should exercise caution before initiating new long positions, as valuation appears stretched relative to the industry.
• Monitor the bank's highly concentrated commercial loan portfolio, which at 81.2% of total loans represents the single largest risk factor and a key area of vulnerability in a shifting economic environment.
• For existing shareholders, the attractive 4.03% dividend yield and ongoing buybacks may justify a hold strategy, but it is critical to watch for any deterioration in loan quality or failure to control rising non-interest expenses.
• The fulfillment of the projected 5-7% NII growth for 2025 is a crucial catalyst; therefore, upcoming NII figures and management commentary on net interest margin (NIM) should be scrutinized to validate the current outlook.